Discover European Penny Stocks To Watch In May 2025

Simply Wall St

As European markets experience a boost in sentiment following the U.S.-China trade de-escalation, investors are keenly observing opportunities across various sectors. Penny stocks, while often considered speculative, remain an intriguing investment area due to their potential for growth and value. These smaller or newer companies can offer significant returns when supported by strong financials, and we'll highlight three such stocks that combine balance sheet strength with promising long-term prospects.

Top 10 Penny Stocks In Europe

NameShare PriceMarket CapRewards & Risks
Bredband2 i Skandinavien (OM:BRE2)SEK2.295SEK2.2B✅ 4 ⚠️ 1 View Analysis >
KebNi (OM:KEBNI B)SEK1.688SEK457.71M✅ 3 ⚠️ 4 View Analysis >
Transferator (NGM:TRAN A)SEK2.34SEK226.76M✅ 2 ⚠️ 3 View Analysis >
Angler Gaming (NGM:ANGL)SEK3.74SEK280.44M✅ 4 ⚠️ 2 View Analysis >
Hifab Group (OM:HIFA B)SEK3.40SEK206.85M✅ 2 ⚠️ 2 View Analysis >
IMS (WSE:IMS)PLN4.10PLN138.97M✅ 3 ⚠️ 2 View Analysis >
Cellularline (BIT:CELL)€2.68€56.53M✅ 4 ⚠️ 2 View Analysis >
Netgem (ENXTPA:ALNTG)€0.994€33.29M✅ 3 ⚠️ 2 View Analysis >
Fondia Oyj (HLSE:FONDIA)€4.73€17.69M✅ 2 ⚠️ 3 View Analysis >
Deceuninck (ENXTBR:DECB)€2.205€304.43M✅ 3 ⚠️ 1 View Analysis >

Click here to see the full list of 447 stocks from our European Penny Stocks screener.

Let's dive into some prime choices out of the screener.

NX Filtration (ENXTAM:NXFIL)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: NX Filtration N.V. develops, produces, and sells hollow fiber membrane modules globally, with a market cap of €238.02 million.

Operations: The company's revenue is derived from two segments: Clean Municipal Water, contributing €3.72 million, and Sustainable Industrial Water, accounting for €6.36 million.

Market Cap: €238.02M

NX Filtration N.V., with a market cap of €238.02 million, reported revenue growth to €11.08 million for 2024, up from €8.05 million the previous year, but remains unprofitable with a net loss of €23.09 million. Despite being removed from the Netherlands ASCX AMS Small Cap Index recently, the company maintains sufficient cash runway for over three years and has more cash than debt, indicating financial stability in the short term. However, profitability is not expected within the next three years as losses have historically increased by 37.7% annually over five years while revenue is forecasted to grow significantly at 48.14% per year.

ENXTAM:NXFIL Financial Position Analysis as at May 2025

AFYREN SAS (ENXTPA:ALAFY)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: AFYREN SAS offers sustainable solutions by producing products from non-food biomass to replace petroleum-based ingredients, with a market cap of €58.49 million.

Operations: The company generates revenue from its Chemicals segment, amounting to €2.86 million.

Market Cap: €58.49M

AFYREN SAS, with a market cap of €58.49 million, focuses on sustainable solutions from non-food biomass but remains unprofitable and lacks meaningful revenue at €2.86 million. Despite this, the company is financially stable in the short term with assets exceeding liabilities and more cash than debt. Recent strategic appointments to its Executive Committee aim to bolster industrial capabilities as its first biorefinery nears completion. Although earnings have not improved, revenue is projected to grow significantly by 48.31% annually, supported by a seasoned management team and reduced debt levels over five years from 50.7% to 5.8%.

ENXTPA:ALAFY Financial Position Analysis as at May 2025

IMS (WSE:IMS)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: IMS S.A., along with its subsidiaries, focuses on providing sensory marketing services in Poland and has a market cap of PLN138.97 million.

Operations: IMS S.A. does not report specific revenue segments.

Market Cap: PLN138.97M

IMS S.A., with a market cap of PLN138.97 million, has demonstrated strong financial performance, reporting net income growth from PLN8.61 million to PLN11.06 million over the past year despite a slight decline in sales. The company's earnings growth of 28.5% surpasses both its five-year average and industry benchmarks, indicating robust profitability with high-quality earnings and an impressive return on equity of 20.8%. While operating cash flow effectively covers debt obligations, short-term liabilities exceed assets, posing potential liquidity concerns. Despite these challenges, IMS maintains stable weekly volatility and forecasts steady revenue growth at 8.36% annually.

WSE:IMS Revenue & Expenses Breakdown as at May 2025

Turning Ideas Into Actions

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if NX Filtration might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com